Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 May 15;17(10):3907-12.
doi: 10.1523/JNEUROSCI.17-10-03907.1997.

Dissociation of tolerance and dependence for opioid peripheral antinociception in rats

K O Aley  1 , J D Levine
Affiliations

Dissociation of tolerance and dependence for opioid peripheral antinociception in rats

K O Aley et al. J Neurosci. .

Abstract

Repeated peripheral administration of the micro-opioid agonist [D-Ala2,N-Me-Phe4,gly5-ol] enkephalin (DAMGO) produces acute tolerance and dependence on its peripheral antinociceptive effect against prostaglandin E2 (PGE2)-induced mechanical hyperalgesia. In this study we evaluated the roles of protein kinase C (PKC) and nitric oxide (NO) in the development of this tolerance and dependence. Repeated administration of PKC inhibitors chelerythrine and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride with DAMGO did not alter the tolerance to DAMGO; however, dependence (defined as naloxone-induced withdrawal hyperalgesia) was blocked. Repeated administration of N-(n-heptyl)-5-chloro-1-naphthalenesulfonamide, a PKC activator, which alone did not produce tolerance, mimicked the dependence produced by DAMGO. Repeated administration of the NO synthase inhibitor NG-methyl-L-arginine with DAMGO blocked the development of tolerance to DAMGO but had no effect on the development of dependence. Repeated administration of L-arginine, a NO precursor, mimicked tolerance produced by repeated administration of DAMGO (i.e. , the antinociceptive effect of DAMGO was lost); however, L-arginine did not mimic dependence. These findings suggest that the development of acute tolerance and dependence on the peripheral antinociceptive effects of DAMGO have different, dissociable mechanisms. Specifically, PKC is involved in development of mu-opioid dependence, whereas the NO signaling system is involved in the development of mu-opioid tolerance.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Effect of PGE2 (100 ng,PGE2; n = 24), DAMGO (1 μg) plus PGE2 (DAMGO+PGE2; n = 24), chelerythrine (1 μg) hourly × 3 and at the fourth hour PGE2 (Chx3,PGE2; n = 12) or DAMGO plus PGE2 (Ch×3,DAMGO+PGE2;n = 12), H-7 hourly × 3 and at the fourth hour DAMGO plus PGE2 (H7×3,DAMGO+PGE2;n = 12), DAMGO hourly × 3 and at the fourth hour DAMGO plus PGE2 (DAMGO×3,DAMGO+PGE2;n = 18), chelerythrine plus DAMGO hourly × 3 and at the fourth hour DAMGO plus PGE2[(Ch+DAMGO)×3,DAMGO+PGE2; n = 12], H-7 plus DAMGO hourly × 3 and at the fourth hour DAMGO plus PGE2 [(H7+DAMGO)×3,DAMGO+PGE2;n = 12] on mechanical paw-withdrawal threshold. In this and subsequent figures, * p < 0.05;NS, not statistically significant.
Fig. 2.
Fig. 2.
Effect of DAMGO hourly × 3 and at the fourth hour naloxone (DAMGO×3,Nal;n = 16), vehicle (saline) hourly × 3 and at the fourth hour naloxone methyliodide (Veh×3,Nal;n = 6), chelerythrine plus DAMGO hourly × 3 and at the fourth hour naloxone methyliodide [(Ch+DAMGO)×3,Nal; n = 12], H-7 plus DAMGO hourly × 3 and at the fourth hour naloxone methyliodide [(H7+DAMGO)×3,Nal; n= 12] on mechanical paw-withdrawal threshold.
Fig. 3.
Fig. 3.
A, Effect of SC-10 hourly × 3 (SC10×3; n = 16), SC-10 hourly × 3 and at the fourth hour PGE2(SC10×3,PGE2; n = 6) or DAMGO plus PGE2 (SC10×3,DAMGO+PGE2;n = 10), saline hourly × 3 and at the fourth hour DAMGO plus PGE2 (Veh×3,DAMGO+PGE2;n = 8) on mechanical paw-withdrawal threshold.B, Effect of DAMGO hourly × 3 and at the fourth hour naloxone methyliodide (DAMGO×3,Nal;n = 16), DAMGO hourly × 3 and at the fourth hour vehicle (DAMGO×3,Veh; n = 6), SC-10 hourly × 3 and at the fourth hour naloxone methyliodide (SC10×3,Nal; n = 16), SC-10 hourly × 3 and at the fourth hour vehicle (SC10×3,Veh; n = 8), vehicle hourly × 3 and at the fourth hour naloxone methyliodide (Veh×3,Nal; n = 6) on mechanical paw-withdrawal threshold.
Fig. 4.
Fig. 4.
Effect of PGE2 (PGE2), NMLA plus PGE2 (NMLA+PGE2; n = 10), NMLA hourly × 3 (NMLA×3; n = 6), NMLA hourly × 3 and 72 hour post-PGE2 [NMLA×3,PGE2(72 h post); n= 12], NMLA plus DAMGO hourly × 3 and PGE2 72 hour later [(NMLA+DAMGO)×3,PGE2(72 h post);n = 12], NMLA plus DAMGO hourly × 3 and 72 hr post DAMGO plus PGE2[(NMLA+DAMGO)×3,DAMGO+PGE2(72 h post);n = 12], and DAMGO hourly × 3 and DAMGO plus PGE2 72 hr post [DAMGO×3,DAMGO+PGE2(72 h post); n = 8] on mechanical paw-withdrawal threshold.
Fig. 5.
Fig. 5.
Effect of DAMGO hourly × 3 and at the fourth hour naloxone methyliodide (DAMGO×3,Nal;n = 16), vehicle (saline) hourly × 3 and at the fourth hour naloxone methyl iodide (Veh×3,Nal;n = 6), NMLA plus DAMGO × 3 and at the fourth hour naloxone [(NMLA+DAMGO)×3, Nal;n = 10], NMLA plus DAMGO hourly × 3 and at the fourth hour saline [(NMLA+DAMGO)×3,Veh;n = 6] on mechanical paw-withdrawal threshold.
Fig. 6.
Fig. 6.
A, Effect of three hourly injections of vehicle (saline) (Veh×3; n = 6),l-arginine (100 ng) (L-Arg×1;n = 12), three hourly injections ofl-arginine (L-Arg×3; n= 12), 72 hr after three hourly injections of l-arginine [L-Arg×3(72hpost); n = 12], PGE2 72 hr after three hourly injections ofl-arginine [L-Arg×3,PGE2(72hpost);n = 6], PGE2 (PGE2), DAMGO plus PGE2 72 hr after three hourly injections ofl-arginine [L-Arg×3,DAMGO+PGE2(72hpost);n = 12], DAMGO plus PGE2(DAMGO+PGE2), on mechanical paw-withdrawal threshold.B, Effect of three hourly injections of DAMGO and 72 hr after naloxone methyliodide [DAMGO×3,Nal(72hpost)], naloxone methyl iodide 72 hr after three hourly injections ofl-arginine [L-Arg×3,Nal(72hpost);n = 8], vehicle 72 hr after three hourly injections of l-arginine [L-Arg×3,Veh(72hpost); n = 8], on mechanical paw-withdrawal threshold.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aley KO, Green PG, Levine JD. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci. 1995;15:8031–8038. - PMC - PubMed
    1. Bhargava HN. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol. 1995;26:1049–1053. - PubMed
    1. Bhargava HN, Zhao GM. Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of d-Pen2,d-Pen5,enkephalin and morphine in the mouse. Neuropeptides. 1996;30:219–223. - PubMed
    1. Bilsky EJ, Bernstein RN, Wang Z, Sadee W, Porreca Effects of naloxone and d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther. 1996;277:484–490. - PubMed
    1. David C, Davis N, Mason R, Wilson VG. Evidence for functional dissociation of dependence and tolerance in guinea-pig isolated ileal segments following 20 hr exposure to morphine in vitro. Br J Pharmacol. 1993;110:1522–1526. - PMC - PubMed

Publication types

MeSH terms